Literature DB >> 23076834

KDM6A point mutations cause Kabuki syndrome.

Noriko Miyake1, Seiji Mizuno, Nobuhiko Okamoto, Hirofumi Ohashi, Masaaki Shiina, Kazuhiro Ogata, Yoshinori Tsurusaki, Mitsuko Nakashima, Hirotomo Saitsu, Norio Niikawa, Naomichi Matsumoto.   

Abstract

Kabuki syndrome (KS) is a rare congenital anomaly syndrome characterized by a unique facial appearance, growth retardation, skeletal abnormalities, and intellectual disability. In 2010, MLL2 was identified as a causative gene. On the basis of published reports, 55-80% of KS cases can be explained by MLL2 abnormalities. Recently, de novo deletion of KDM6A has been reported in three KS patients, but point mutations of KDM6A have never been found. In this study, we investigated KDM6A in 32 KS patients without an MLL2 mutation. We identified two nonsense mutations and one 3-bp deletion of KDM6A in three KS cases. This is the first report of KDM6A point mutations associated with KS.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23076834     DOI: 10.1002/humu.22229

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  77 in total

Review 1.  Genetic studies in intellectual disability and related disorders.

Authors:  Lisenka E L M Vissers; Christian Gilissen; Joris A Veltman
Journal:  Nat Rev Genet       Date:  2015-10-27       Impact factor: 53.242

Review 2.  X-chromosome inactivation and escape.

Authors:  Christine M Disteche; Joel B Berletch
Journal:  J Genet       Date:  2015-12       Impact factor: 1.166

Review 3.  Genomics of lymphoid malignancies reveal major activation pathways in lymphocytes.

Authors:  Birgit Knoechel; Jens G Lohr
Journal:  J Autoimmun       Date:  2013-07-21       Impact factor: 7.094

Review 4.  Examining the impact of gene variants on histone lysine methylation.

Authors:  Capucine Van Rechem; Johnathan R Whetstine
Journal:  Biochim Biophys Acta       Date:  2014-05-23

5.  Extensive cellular heterogeneity of X inactivation revealed by single-cell allele-specific expression in human fibroblasts.

Authors:  Marco Garieri; Georgios Stamoulis; Xavier Blanc; Emilie Falconnet; Pascale Ribaux; Christelle Borel; Federico Santoni; Stylianos E Antonarakis
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-03       Impact factor: 11.205

6.  A UTX-MLL4-p300 Transcriptional Regulatory Network Coordinately Shapes Active Enhancer Landscapes for Eliciting Transcription.

Authors:  Shu-Ping Wang; Zhanyun Tang; Chun-Wei Chen; Miho Shimada; Richard P Koche; Lan-Hsin Wang; Tomoyoshi Nakadai; Alan Chramiec; Andrei V Krivtsov; Scott A Armstrong; Robert G Roeder
Journal:  Mol Cell       Date:  2017-07-20       Impact factor: 17.970

Review 7.  Zebrafish models of orofacial clefts.

Authors:  Kaylia M Duncan; Kusumika Mukherjee; Robert A Cornell; Eric C Liao
Journal:  Dev Dyn       Date:  2017-09-25       Impact factor: 3.780

Review 8.  Array comparative genomic hybridization and genomic sequencing in the diagnostics of the causes of congenital anomalies.

Authors:  Krzysztof Szczałuba; Urszula Demkow
Journal:  J Appl Genet       Date:  2016-11-18       Impact factor: 3.240

9.  Precocious neuronal differentiation and disrupted oxygen responses in Kabuki syndrome.

Authors:  Giovanni A Carosso; Leandros Boukas; Jonathan J Augustin; Ha Nam Nguyen; Briana L Winer; Gabrielle H Cannon; Johanna D Robertson; Li Zhang; Kasper D Hansen; Loyal A Goff; Hans T Bjornsson
Journal:  JCI Insight       Date:  2019-10-17

10.  RAP1-mediated MEK/ERK pathway defects in Kabuki syndrome.

Authors:  Nina Bögershausen; I-Chun Tsai; Esther Pohl; Pelin Özlem Simsek Kiper; Filippo Beleggia; E Ferda Percin; Katharina Keupp; Angela Matchan; Esther Milz; Yasemin Alanay; Hülya Kayserili; Yicheng Liu; Siddharth Banka; Andrea Kranz; Martin Zenker; Dagmar Wieczorek; Nursel Elcioglu; Paolo Prontera; Stanislas Lyonnet; Thomas Meitinger; A Francis Stewart; Dian Donnai; Tim M Strom; Koray Boduroglu; Gökhan Yigit; Yun Li; Nicholas Katsanis; Bernd Wollnik
Journal:  J Clin Invest       Date:  2015-08-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.